Editorial: Covid-19 and Diabetes

Front Endocrinol (Lausanne). 2022 Jun 13:13:933562. doi: 10.3389/fendo.2022.933562. eCollection 2022.

Authors

Mohamed Abu-Farha¹, Susanna Hofmann², Hamad Ali^{3

4}

Affiliations

¹ Biochemistry and Molecular Biology Department, Dasman Diabetes Institute, Dasman, Kuwait.
² Institute of Diabetes and Regeneration Research, Helmholtz Diabetes Center, Helmholtz Center Munich, Neuherberg, Germany.
³ Department of Genetics and Bioinformatics, Dasman Diabetes Institute, Dasman, Kuwait.
⁴ Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Health Sciences Center (HSC), Kuwait University, Jabriya, Kuwait.

No abstract available

Keywords: COVID-19; diabetes; diabetes treatment; glycemic control; metformin.

Publication types

Editorial

MeSH terms

COVID-19*
Diabetes Mellitus* / epidemiology
Diabetes Mellitus* / therapy
Humans
Hypoglycemic Agents
Metformin*

Substances

Hypoglycemic Agents
Metformin